Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TOMI’s SteraMist platform is commercially validated for high-level disinfection and decontamination, showing efficacy against spores and hard-to-kill pathogens (e.g., Geobacillus stearothermophilus, Clostridioides difficile), with FDA and EPA validations for hospital and healthcare use. The products are widely used in regulated environments; recent validation includes deployment in eye health manufacturing sites and US/Europe hospitals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TOMI Environmental Solutions.